Abstract
The Turkish pharmaceutical market is relatively small, at around US$5.6
billion in 2006, at consumer prices. This report is ideal for executives
wanting to understand the key drivers in the pharmaceutical market and have
access to a wealth of statistical data, including five-year market
projections. Included with the report are 3 free quarterly updated outlook
reports, enabling you to keep up to date with market developments for a year.
Includes 3 quarterly updated outlook reports!
Health sector development in Turkey has been far from dynamic in recent years,
largely due to the effects of the earthquakes that hit the northern region in
1999; the draining effect on the national economy has been considerable.
However, with the launch of the Second Health Project, with aid from the World
Bank, there are signs of renewed activity in the sector. Turkey continues to
take further steps towards EU accession and is currently in talks. However,
not all member states are happy with Turkey' s possible membership. Austria for
example, would far rather enter into a "privileged partnership" with Turkey
than accept it as a full member; other members are also bitterly divided over
the issue. The accession bid sees national legislation, including regulation
of the healthcare sector, becoming increasingly aligned with EU guidelines.
In a stark contrast to the health sector, the pharmaceutical sector is
dominated by the private sector, which handles the majority of all production,
import, wholesale, storage and retail of medicaments in Turkey; the only
exception is the SSK-owned pharmaceutical plant, which provides drugs solely
to SSK facilities. A large share of the private sector production is under
licence to foreign companies. Turkey spends a disproportionately large amount
on pharmaceutical products. The high percentage of drugs expenditure in terms
of total health expenditure is as much a reflection of low health spending as
it is of high pharmaceutical expenditure. Due to the sensitive economic
climate, the majority of the population is sensitive to fluctuations in drug
prices.
The Turkish pharmaceutical market is relatively small, at around US$5.6
billion in 2006, at consumer prices. Industry concern continues to revolve
around Turkey' s integration into the international pharmaceutical community,
especially with regard to compliance with WTO regulations. The threat of an
influx of foreign-manufactured products onto the EU market has been the
catalyst for the local drug industry to oppose harmonisation. However, with
the appointment of a pro-EU Director of Pharmaceuticals at the Directorate of
Pharmaceuticals of the Ministry of Health, international disquiet looks set to
decline as the process of harmonisation gathers pace.
MARKET OUTLOOK
- Current market size
- Unique 5-year market projections
- Market outlook
- Market structure
- Includes data on imports and exports
- Market developments
- Recent and impending developments with respect to key issues such as
regulation, health facilities and government policy
- Key national data projections
BACKGROUND DATA
- Population data, including growth trends and age structure
- Demographic indicators detailing principal causes of death and morbidity
HEALTHCARE SYSTEM
- Health expenditure
- Expenditure by source of funding and type
- Hospital services
- Hospital data such as beds by type, specialty, patient admissions,
occupancy and surgical procedures
- Outpatient care
- Medical personnel
- Data on healthcare professionals covering such areas as doctors by
specialty and nursing staff
ACCESSING THE PHARMACEUTICAL MARKET
- Regulatory environment
- Patent protection & intellectual property rights
- Pricing & reimbursement
- Distribution channels
- Domestic production
CONTACT DETAILS
- For healthcare organisations and trade associations
Compelling reasons to buy this Espicom market report
Espicom is a leading provider of market and company information for business.
In addition to this analysis, Espicom provides detailed management reports on
over 60 established and emerging pharmaceutical markets around the world.
- Includes - FREE - three quarterly updated outlook reports on the
Turkish pharma market
- Unique and original market forecasts
- Insightful interpretation of market trends and developments
- Fantastic value - no-one else produces such quality data so cost
effectively
- Over 25 years continuous pharmaceutical market experience
- A team of full-time researchers and analysts
- Unbeatable access to primary sources
- Independent and impartial
View Cart
